These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 26354797

  • 21. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience.
    Saadoun D, Lambert M, Mirault T, Resche-Rigon M, Koskas F, Cluzel P, Mignot C, Schoindre Y, Chiche L, Hatron PY, Emmerich J, Cacoub P.
    Circulation; 2012 Feb 14; 125(6):813-9. PubMed ID: 22230484
    [Abstract] [Full Text] [Related]

  • 22. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
    de Souza AW, da Silva MD, Machado LS, Oliveira AC, Pinheiro FA, Sato EI.
    Scand J Rheumatol; 2012 May 14; 41(3):227-30. PubMed ID: 22400913
    [Abstract] [Full Text] [Related]

  • 23. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents.
    Sener S, Basaran O, Kaya Akca U, Atalay E, Kasap Cuceoglu M, Balik Z, Aliyev E, Bayindir Y, Batu ED, Hazirolan T, Bilginer Y, Ozen S.
    Rheumatology (Oxford); 2022 Nov 28; 61(12):4885-4891. PubMed ID: 35262635
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Infliximab in Takayasu arteritis: a safe alternative?
    Karageorgaki ZT, Mavragani CP, Papathanasiou MA, Skopouli FN.
    Clin Rheumatol; 2007 Jun 28; 26(6):984-7. PubMed ID: 16633710
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients.
    Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D, French Takayasu Network.
    Circulation; 2017 Sep 19; 136(12):1114-1122. PubMed ID: 28701469
    [Abstract] [Full Text] [Related]

  • 30. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.
    Int J Rheum Dis; 2012 Jun 19; 15(3):330-5. PubMed ID: 22709496
    [Abstract] [Full Text] [Related]

  • 31. Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry.
    Favalli EG, Pregnolato F, Biggioggero M, Becciolini A, Penatti AE, Marchesoni A, Meroni PL.
    Arthritis Care Res (Hoboken); 2016 Apr 19; 68(4):432-9. PubMed ID: 26556048
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review.
    Abisror N, Mekinian A, Lavigne C, Vandenhende MA, Soussan M, Fain O, Club Rhumatismes et Inflammation, and SNFMI.
    Autoimmun Rev; 2013 Oct 19; 12(12):1143-9. PubMed ID: 23820042
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM.
    Internist (Berl); 2019 Oct 19; 60(10):1059-1073. PubMed ID: 31471629
    [Abstract] [Full Text] [Related]

  • 36. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
    Loricera J, Blanco R, Hernández JL, Castañeda S, Humbría A, Ortego N, Bravo B, Freire M, Melchor S, Mínguez M, Salvatierra J, González-Vela C, Calvo-Río V, Santos-Gómez M, Pina T, González-Gay MA.
    Clin Exp Rheumatol; 2016 Oct 19; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
    [Abstract] [Full Text] [Related]

  • 37. [Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
    Liao H, Pan LL, Du J, Gao N, Wang T.
    Zhonghua Nei Ke Za Zhi; 2019 Jun 01; 58(6):444-448. PubMed ID: 31159524
    [Abstract] [Full Text] [Related]

  • 38. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature.
    Batu ED, Sönmez HE, Hazırolan T, Özaltın F, Bilginer Y, Özen S.
    Semin Arthritis Rheum; 2017 Feb 01; 46(4):529-535. PubMed ID: 27515155
    [Abstract] [Full Text] [Related]

  • 39. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
    Finckh A, Simard JF, Gabay C, Guerne PA, SCQM physicians.
    Ann Rheum Dis; 2006 Jun 01; 65(6):746-52. PubMed ID: 16339288
    [Abstract] [Full Text] [Related]

  • 40. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
    Tamura N, Maejima Y, Tezuka D, Takamura C, Yoshikawa S, Ashikaga T, Hirao K, Isobe M.
    J Cardiol; 2017 Sep 01; 70(3):278-285. PubMed ID: 27989502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.